WithdrawnNot Applicable

A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease

Stopped: Company focus shifted

United States0Started 2020-03-02

Plain-language summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Parkinson's Disease.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
✓. Male or female patients of any age (interest is given to children to compare with mothers).
✓. Diagnosis of Parkinson's Disease

Exclusion criteria

✕. Refusal to sign informed consent form
✕. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
✕. Postoperative stoma, ostomy, or ileoanal pouch
✕. Participation in any experimental drug protocol within the past 12 weeks
✕. Treatment with total parenteral nutrition
✕. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
✕. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

What they're measuring

Correlation of Microbiome to Parkinson's Disease via Relative Abundance Found in Microbiome Sequencing

Timeframe: One Year

Trial details

NCT IDNCT04148326

SponsorProgenaBiome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03

View on ClinicalTrials.gov More Parkinson Disease trials